JAGX · Jaguar Health, Inc. · Share Buybacks
$2.63
-0.19 (-6.74%)
At close · Oct 20
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 19, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions, along with recurring operating losses and an accumulated deficit, raise substantial doubt about the Company's ability to continue as a going concern for a period of one year from the issuance of these consolidated financial statements. While management believes this infusion improves our liquidity, it does not fully alleviate the conditions that raise substantial doubt about our ability to continue as a going concern for one year from the issuance of these financial statements.”View the 10-Q filed Aug 19, 2026
Market Cap
$1.81M
Shares
689,107
Volume · Oct 20
266.67K
Avg daily vol (3 sessions)
557.76K
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2021-12-10 | 2022-02-02 | $75,000,000 | — | 2024-12-10 expired | 10-Q , filed 2025-08-14 |
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2018-12-31 | $30 | 10-K, filed 2020-04-03 |